COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,843 Articles (22,553 medRxiv, 8,290 bioRxiv)

Most recent first Previous |  Page 1193: Articles 11921-11930  | Next

Gene networks under circadian control exhibit diurnal organization in primate organs
Li, J., Nie, P., Turck, C., Wang, G.-Z.
10.1101/2021.09.17.460870 — Posted: 2021-09-21
Mechanistic Insights into the Effects of Key Mutations on SARS-CoV-2 RBD-ACE2 Binding
Aggarwal, A., Naskar, S., Maroli, N., Gorai, B., Dixit, N. M., Maiti, P. K.
10.1101/2021.09.20.461041 — Posted: 2021-09-21
IL13Pred: A method for predicting immunoregulatory cytokine IL-13 inducing peptides for managing COVID-19 severity.
Jain, S., Dhall, A., Patiyal, S., Raghava, G. P. S.
10.1101/2021.09.19.460950 — Posted: 2021-09-21
A novel B.1.1.523 SARS-CoV-2 variant that combines many spike mutations linked to immune evasion with current variants of concern
van der Veer, B. M. J. W., Dingemans, J., van Alphen, L. B., Hoebe, C. J., Savelkoul, P. H. M.
10.1101/2021.09.16.460616 — Posted: 2021-09-21
Long Term Physical, Mental and Social Health Effects of COVID-19 in the Pediatric Population: A Scoping Review
Borel, M., Xie, L., Mihalcea, A., Kahn, J., Messiah, S. E.
10.1101/2021.09.17.21263743 — Posted: 2021-09-21
The Relationship of Vaccine Uptake and COVID-19 Infections among Nursing Home Staff and Residents in Missouri
Scroggins, S., Ellis, M., Shacham, E.
10.1101/2021.09.16.21263714 — Posted: 2021-09-21
Optimized Post-Vaccination Strategies and Preventative Measures for SARS-CoV-2
Pettit, R. W., Peng, B., Yu, P., Matos, P., Greninger, A. L., McCashin, J., Amos, C. I.
10.1101/2021.09.17.21263723 — Posted: 2021-09-21
Single-Dose SARS-CoV-2 Vaccination With BNT162b2 and AZD1222 Induce Disparate Th1 Responses and IgA Production
Müller, M., Volzke, J., Subin, B., Müller, S., Sombetzki, M., Reisinger, E. C., Müller-Hilke, B.
10.1101/2021.09.17.21263726 — Posted: 2021-09-21 Discussion: Onsite
COVID-19 vaccination rates among health care workers by immigrant background. A nation-wide registry study from Norway.
Kraft, K. B., Elgersma, I. H., Lyngstad, T. M., Elstrom, P., Telle, K. E.
10.1101/2021.09.17.21263619 — Posted: 2021-09-21
Deleterious drugs in COVID-19: a rapid systematic review and meta-analysis
Holder, M. W., Heeney, C., Malden, S., Perera, U., Sheikh, A.
10.1101/2021.09.17.21262724 — Posted: 2021-09-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).